Open access
68
Views
3
CrossRef citations to date
0
Altmetric
Original Research
Clinical outcomes with olanzapine long-acting injection: impact of the 3-hour observation period on patient satisfaction and well-being
Ernie Anand1 Neuroscience Medical Affairs, Eli Lilly & Company Ltd, Windlesham, UKCorrespondence[email protected]
, Lovisa Berggren2 Global Statistical Sciences, Lilly Deutschland GmbH, Bad Homburg, Germany
, John Landry3 Global Statistical Sciences, Eli Lilly Canada Inc., Toronto, ON, Canada
, Ágoston Tóth4 Neuroscience, Lilly Hungary, Budapest, Hungary
& Holland C Detke5 Psychiatry and Pain Disorders, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA
Pages 2737-2743
|
Published online: 25 Oct 2016
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.